Administration of dapagliflozin in RHD mitral stenosis patients has been shown to improve left atrial function, as evidenced by improvements in Cn, the MPG value of the mitral valve, and NT-pro BNP levels. This evidence concerns the gene NPPB and rheumatic heart disease.